Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
批准号:
10254302
负责人:
George A. Belov
金额:
$22.82万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-04 至 2022-08-31
关键词:
Amino Acid SequenceAntibodiesAntigenic DiversityAntigensAsthmaAttenuated VaccinesBiologicalCD8B1 geneCapsidCapsid ProteinsCellsChinaCodeCoxsackie VirusesCytotoxic T-LymphocytesDataDevelopmentDiabetes MellitusDilated CardiomyopathyDiseaseDisease OutbreaksEconomic BurdenEconomicsElementsEncephalomyelitisEnterovirusEnterovirus 68Enterovirus 71Enterovirus InfectionsEpidemiologyFamily PicornaviridaeFlavivirusGene PoolGenetic RecombinationGenomeHealth ResourcesHuman poliovirusImmune responseImmunityImmunizationImmunizeImmunodominant AntigensIn VitroInactivated VaccinesIndividualInfectionInsulin-Dependent Diabetes MellitusLifeLinkMediatingMembrane ProteinsMusMyocarditisNonstructural ProteinOralOral Poliovirus VaccineParalysedPathologyPhasePoliomyelitisPoliovirus VaccinesPrimatesPropertyProteinsPublic HealthRNARNA VirusesRepliconRhinovirusRoleSchemeSerotypingSpecificityStretchingStructureSystemT cell responseT-LymphocyteTimeVaccinationVaccinesViralViral ProteinsVirionVirusVirus-like particleantigen-specific T cellsbasecytotoxiccytotoxicityhuman pathogenin vivomeetingsmouse modelneutralizing antibodynovelpathogenpreventproduct developmentprotective efficacyresponsevaccine accessvaccine developmentvaccine efficacy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Multiple enteroviruses are associated with life-threatening and economically important diseases, yet the
licensed vaccines are only available against poliovirus and enterovirus 71. The antigenic diversity of
enterovirus capsids restricts the protective efficacy of vaccines only to antigenically very similar viruses. Even
for closely related polioviruses, the three serotypes must be covered by separate vaccine products. In most
cases such targeted vaccine development approach cannot even be implemented, either because of the
biological constraints, such as antigenic diversity of rhinoviruses, or economic unattractiveness of developing
vaccines against viruses only sporadically associated with severe pathologies, such as Coxsackie viruses
linked to the development of diabetes, myocarditis and dilated cardiomyopathy. Thus, in spite of a pressing
need for an effective vaccine coverage of existing and emerging enterovirus threats, the current
vaccine development strategies focused on inducing neutralizing antibodies against capsid antigens
are intrinsically incapable of delivering products meeting this demand.
Yet, unlike the antigenically diverse capsids, the non-structural proteins of these viruses feature a significant
degree of conservation, so that the elements of the replication machinery are essentially interchangeable
among diverse enteroviruses, resulting in the phenomenon of extensive recombination of enterovirus
genomes.
In this application we present data to support, and propose to explore the hypothesis that posits the following:
Antigenically diverse enteroviral capsids are immuno-dominant antigens which divert the development
of immune response away from the conserved non-structural proteins. Consequently, by removing the
input of the capsid proteins, the development of the immune response to enterovirus infection can be rerouted
towards the conserved membrane-associated proteins of the replication machinery. likely resulting in: 1.
Refocusing the protection mechanism from that based mostly on neutralizing antibodies to the one
mediated by T-cell cytotoxicity, and 2. Providing protection against broad spectrum of enteroviruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infection-specific lipid metabolism as a target to control enterovirus infections
-
批准号:10450249
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2022
-
负责人:George A. Belov
-
依托单位:
Infection-specific lipid metabolism as a target to control enterovirus infections
-
批准号:10597236
-
项目类别:
-
资助金额:$36.57万
-
财政年份:2022
-
负责人:George A. Belov
-
依托单位:
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
-
批准号:10041960
-
项目类别:
-
资助金额:$18.96万
-
财政年份:2020
-
负责人:George A. Belov
-
依托单位:
Role of host protein GBF1 in organizing enterovirus replication complexes
-
批准号:9295959
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2016
-
负责人:George A. Belov
-
依托单位:
Role of host protein GBF1 in organizing enterovirus replication complexes
-
批准号:9158557
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2016
-
负责人:George A. Belov
-
依托单位:
海外基金